Sen. Stabenow: New GAO Report Reveals Underreported Taxpayer Contributions to Pharma Research
May 10, 2023
May 10, 2023
WASHINGTON, May 10 -- Sen. Debbie Stabenow, D-Michigan, issued the following news release on May 9, 2023:
The U.S. Government Accountability Office released a new report today that found the amount of taxpayer contributions to pharmaceutical research and development has frequently been underreported in patent filings, while pharmaceutical companies continue to cite R&D expenditures as justification for raising drug prices. In response to the report, which was requested by Senato . . .
The U.S. Government Accountability Office released a new report today that found the amount of taxpayer contributions to pharmaceutical research and development has frequently been underreported in patent filings, while pharmaceutical companies continue to cite R&D expenditures as justification for raising drug prices. In response to the report, which was requested by Senato . . .